- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04234165
Safety and Efficacy of Bipolar vs Monopolar Transurethral Resection of Bladder Tumor-A Randomized Controlled Trial
Safety and Efficacy of Bipolar vs Monopolar Transurethral Resection of Bladder Tumor-A
Study design:
This was a single center, parallel arm, randomized, controlled trial done at Tribhuvan University Teaching Hospital,Institute Of Medicine from May 2017 to April 2018. The allocation ratio was 1:1.
Inclusion criteria: All patients undergoing Transurethral Resection of Bladder Tumor for suspected bladder tumors.
Exclusion criteria were: Consent withdrawal, bladder tumour other than in the lateral wall, unfit for spinal anesthesia and need of general anesthesia or obturator nerve block.
Methodology:
All patients suspected to have bladder cancer were subjected to imaging or cystoscopy and with confirmation of the diagnosis; they were randomized into two arms of TURBT. Spinal anesthesia was used in all cases. To overcome the potential confounding effect on our primary end point, obturator jerk, nerve block was not used.
Cystoscopy was done first and the findings were noted before proceeding to TURBT.
Tumors were resected in block from periphery to center with the stalk resected last. An additional sample of deep muscle was obtained from the tumor base and sent for histopathological examination in different containers.
All study variables were recorded in Per forma during the operation and in post operative period. Hemoglobin and sodium level was determined in immediate post operative period.
Postoperative irrigation was done with normal saline in both the resection groups and continued till the urine was clear. The catheter was removed after 48 hours in uncomplicated cases and patients were discharged. Patients were followed up in OPD at 2 weeks with the
Study Overview
Detailed Description
All patients suspected to have bladder cancer were subjected to imaging or cystoscopy and with confirmation of the diagnosis; they were randomized into two arms of TURBT. Spinal anesthesia was used in all cases.
To overcome the potential confounding effect on our primary end point, obturator jerk, nerve block was not used.
Cystoscopy was done first and the findings were noted before proceeding to TURBT.
Monopolar resection was done using 1.5% Glycine solution at 110 watt cutting, and 70 watt coagulation power (Covidien Valley-lab Force Fx TM) with Karl Storz 26f resectoscope and loop (8mm width and 5mm depth) with 300 telescope. Bipolar resection was done with 0.9% Normal Saline with digital impedence dependent cutting (power range 150-250 watt) and 80 watt coagulation power (Bowa Arc 400) with Karl Storz 26f resectoscope and loop (6mm width and 5mm depth) with 300 telescope.
Tumors were resected in block from periphery to center with the stalk resected last. An additional sample of deep muscle was obtained from the tumor base and sent for histopathological examination in different containers. All study variables were recorded in Per forma during the operation and in post operative period. Hemoglobin and sodium level was determined in immediate post operative period.
Postoperative irrigation was done with normal saline in both the resection groups and continued till the urine was clear. The catheter was removed after 48 hours in uncomplicated cases and patients were discharged. Patients were followed up in Out Patient Department at 2 weeks with the histopathological report for or when necessary.
Study outcome:
The incidence of obturator jerk, bladder perforation, resection time, decrease in hemoglobin and serum sodium, clot retention, need for blood transfusion, need for recoagulation and TUR syndrome were recorded for the cases in both arms. All resected specimen were evaluated by pathologist for quality by determining the presence of deep muscle in the sample and comparing the degree of cautery artifact. Severe artifact was defined as more than 50% cautery artifact in most chips.
Statistical Analysis:
Sample size (n) was calculated using 80% power and a 95% significance level for obturator jerk, assuming a 30% incidence for the monopolar system and a 5% incidence for the bipolar system. These values were arrived at after a comprehensive literature review. The sample size was determined with the formula n= K {P1(1-P1) x P2(1-P2)}/ )P1-P2)2, Where:
N= sample size P1= prevalence of obturator jerk in Monopolar TURBT P2= prevalence of obturator jerk in Bipolar TURBT K= constant (7.9 for 80% power of study and 0.05 level of significance)
A sample size of 33 in each arm was calculated using above formula. Estimating a drop out of 10%, we decided to include at least 37 patients in each arm. A computer generated random number was used to allocate eligible patients in to monopolar or bipolar resection arm. Data analysis was done using Statistical Package for Social Sciences (SPSS) version 21. Significance was determined using the independent sample t-test for quantitative variables and the chi-square test for qualitative data. P value of <0.05 was considered statistically significant.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Three
-
Kathmandu, Three, Nepal, 44600
- TUTH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients undergoing TURBT for suspected bladder tumors.
Exclusion Criteria:
- Consent withdrawal, bladder tumour other than in the lateral wall, unfit for spinal anesthesia and need of general anesthesia or obturator nerve block.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Monopolar arm
monopolar cautery was used for TURBT
|
different power sources ( bipolar vs monopolar)
|
Experimental: Bipolar Arm
bipolar cautery was used for TURBT
|
different power sources ( bipolar vs monopolar)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
obturator jerk occurrence
Time Frame: during TURBT
|
occurrence of obturator jerk (yes/no) will be recorded
|
during TURBT
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
bladder perforation(yes/no)
Time Frame: during TURBT
|
this parameter will be recorded during operation
|
during TURBT
|
time of resection (minutes
Time Frame: during TURBT
|
this parameters will be recorded during operation
|
during TURBT
|
TUR syndrome (yes/no)
Time Frame: during and after operation
|
this parameters will be recorded during and after operation
|
during and after operation
|
decrease in hemoglobin (mg/dl)
Time Frame: immediate post operative period
|
this parameters will be recorded immediately after operation
|
immediate post operative period
|
serum sodium(meq/l)
Time Frame: immediate post operative period
|
this parameters will be recorded immediately after operation
|
immediate post operative period
|
need for blood transfusion (yes/no)
Time Frame: immediate post operative period
|
this parameters will be recorded immediately after operation
|
immediate post operative period
|
clot retention (yes/no)
Time Frame: immediate post operative period
|
this parameters will be recorded immediately after operation
|
immediate post operative period
|
presence of deep muscle (yes/no)
Time Frame: two weeks after operation ( as per usual availability of histopathology report in the hospital)
|
histo-pathology report will be evaluated for these outcome
|
two weeks after operation ( as per usual availability of histopathology report in the hospital)
|
severy cautery artifact(yes/no)
Time Frame: two weeks after operation ( as per usual availability of histopathology report in the hospital)
|
histo-pathology report will be evaluated for these outcome
|
two weeks after operation ( as per usual availability of histopathology report in the hospital)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 344-(6-11-E)073-074
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on TURBT
-
Benha UniversityRecruiting
-
Gregers G HermannUnknown
-
Mansoura UniversityCompleted
-
Ziv HospitalNot yet recruitingBladder Neoplasm
-
Fundacio PuigvertKARL STORZ Endoscopy-America, Inc.RecruitingBladder Cancer | Urothelial Carcinoma BladderSpain
-
University of TriesteCompletedBladder Cancer | Non Muscle Invasive Bladder CancerItaly
-
Mansoura UniversityUnknown
-
National Cancer Institute (NCI)Recruiting
-
Hospital Universitario de FuenlabradaRecruitingBladder Cancer | Urothelial Carcinoma Recurrent | Bladder Urothelial Carcinoma | Bladder Neoplasm | Bladder Cancer StageSpain
-
Mansoura UniversityUnknownCystoscopy | Bladder Urothelial Carcinoma | Bladder Neoplasm | TURBTEgypt